How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

0 Recensioner
0
Episod
263 of 286
Längd
31min
Språk
Engelska
Format
Kategori
Fakta

Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.


Lyssna när som helst, var som helst

Kliv in i en oändlig värld av stories

  • 1 miljon stories
  • Hundratals nya stories varje vecka
  • Få tillgång till exklusivt innehåll
  • Avsluta när du vill
Starta erbjudandet
SE - Details page - Device banner - 894x1036
Cover for How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

Andra podcasts som du kanske gillar...